Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events

Abstract

BACKGROUND: Epidemiological evidence has suggested a link between beta2-agonists and increased asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists are safe. This is an updated systematic review. OBJECTIVES: To assess the risk of mortality and non-fatal serious adverse events in trials which randomised patients with chronic asthma to regular …

Authors

Cates CJ; Jaeschke R; Schmidt S; Ferrer M

Journal

Cochrane Database of Systematic Reviews, , No. 3,

Publisher

Wiley

DOI

10.1002/14651858.cd006922.pub3

ISSN

1361-6137

Associated Experts

Roman Jaeschke

Professor, Faculty of Health Sciences

Visit profile

Labels